Organization | Lankenau Hospital

Lankenau Hospital Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Wynnewood PA United States (1850)

Organization Overview

First Clinical Trial

1974

NCT00000491

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2010

Timeline

NOW

Now

Alternative names

Lankenau Hospital, Lankenau Institute for Medical Research | Lankenau Institute for Medical Research and The Heart Center, United States | Lankenau Institute for Medical Research, Wynnewood, PA and Bryn Mawr Hospital Outpatient Imaging Center, Bryn Mawr, PA

Active Ingredients

Drugs in Phase 3 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

propranolol (inderal) (1 trial)

Drugs in Phase 2 Trials (3)

betrixaban (bevyxxa) (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (2)

aprepitant (Emend) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Atrial Fibrillation (Phase 2)

Cardiovascular Diseases (Phase 3)

Coronary Disease (Phase 3)

Death, Sudden (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Head and Neck Neoplasms (Phase 2)

Heart Diseases (Phase 3)

Hypoxia (Phase 2)

Infarction (Phase 3)

Ischemia (Phase 3)

Liver Neoplasms (Phase 2)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Rectal Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Ventricular Fibrillation (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 5
# of Trial APIs: 7